Intuitive Surgical highlights robotics growth, shares track sector peers

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-26, 20:13.

Intuitive Surgical, Inc. (US46120E6023) continues to emphasize the uptake of its robotic-assisted surgery systems in hospitals worldwide. The stock, listed on NASDAQ alongside peers such as Medtronic and Stryker, remains closely watched in the medical technology sector according to recent market commentary from major financial portals. NASDAQ data on Intuitive Surgical shares

Robotic surgery footprint and recent metrics

Intuitive Surgical reported in April 2026 that procedure volumes for its robotic systems grew at a double-digit rate year-on-year in the first quarter, driven by general surgery and urology, based on its investor relations materials. The company detailed that global installed base growth in systems such as da Vinci remained robust in the United States and key international markets in that period. Intuitive Surgical Q1 2026 results release

For Q1 2026, Intuitive Surgical disclosed that worldwide da Vinci procedures increased compared with the prior-year quarter, citing continued penetration in soft tissue surgery categories. The company also highlighted higher demand from hospitals seeking minimally invasive options for patients, which supports utilization rates on existing systems and justifies new placements. These operational metrics position the group alongside Medtronic and Stryker in the broader surgical and medical device industry, where technology-enabled procedures are gaining share.

Friday focus on sector and peer performance

On this Friday, investors compare Intuitive Surgical with Medtronic and Stryker as key medical technology names, checking relative valuation and growth expectations via platforms such as MarketScreener and Yahoo Finance. Consensus data compiled by MarketScreener show that a majority of analysts maintain positive ratings on Intuitive Surgical, reflecting its strong procedure growth and high recurring revenue share from instruments and accessories. MarketScreener analyst consensus for Intuitive Surgical

Sector comparisons often reference revenue growth in surgical robotics versus more traditional medical devices, with Intuitive Surgical viewed as a specialized robotics leader, while Medtronic and Stryker operate broader portfolios. Investment research notes summarized on Yahoo Finance point out that Intuitive Surgical has relatively high exposure to hospital capital spending cycles, which can amplify its sensitivity to macroeconomic conditions compared with diversified peers. Yahoo Finance analysis page for ISRG

The product behind Intuitive Surgical revenue

Intuitive Surgical generates a large share of its revenue from the da Vinci Surgical System, which combines a 3D vision cart, surgeon console and patient-side cart to support minimally invasive procedures. The company also earns recurring income from instruments, accessories and service contracts tied to this installed base. Hospitals typically use da Vinci for gynecologic, urologic and general surgeries, adding up to high utilization and steady demand for consumables.

Where Intuitive Surgical stock trades today

Intuitive Surgical shares trade on NASDAQ under the ticker ISRG, with recent quotes around 520.00 US dollars as of 2026-06-26, 18:10, based on NASDAQ market data and cross-checks with major financial websites.

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.